Helicobacter pylori eradication: Current aspects

The paper gives an update on the efficiency of Helicobacter pylori eradication. Triple therapy (a proton pump inhibitor + clarithromycin + amoxicillin) therapy is shown to hold top positions as first-line therapy for H. pylori eradication as before. The leading second-line therapy regimens are quadr...

Full description

Bibliographic Details
Main Authors:	V V Tsukanov, O S Amel'chugova, N N Butorin, O V Tret'iakova, A V Vasiutin
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2013-02-01
Series:	Терапевтический архив
Subjects:	eradication helicobacter pylori
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/31227

id	doaj-7be00c1cb9a24baa8aa5e8950cb6434a
record_format	Article
spelling	doaj-7be00c1cb9a24baa8aa5e8950cb6434a2020-11-25T03:06:44Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422013-02-01852737528243Helicobacter pylori eradication: Current aspectsV V TsukanovO S Amel'chugovaN N ButorinO V Tret'iakovaA V VasiutinThe paper gives an update on the efficiency of Helicobacter pylori eradication. Triple therapy (a proton pump inhibitor + clarithromycin + amoxicillin) therapy is shown to hold top positions as first-line therapy for H. pylori eradication as before. The leading second-line therapy regimens are quadruple and 10-day triple schemes including levofloxacin. This point of view is supported by the Russian Gastroenterology Association. To reduce an increase in H. pylori resistance to clarithromycin, it is advisable to use Klacid (generic name: clarithromycin) in the eradication schemes.https://ter-arkhiv.ru/0040-3660/article/view/31227eradicationhelicobacter pylorihelicobacter pylori
collection	DOAJ
language	Russian
format	Article
sources	DOAJ
author	V V Tsukanov O S Amel'chugova N N Butorin O V Tret'iakova A V Vasiutin
spellingShingle	V V Tsukanov O S Amel'chugova N N Butorin O V Tret'iakova A V Vasiutin Helicobacter pylori eradication: Current aspects Терапевтический архив eradication helicobacter pylori helicobacter pylori
author_facet	V V Tsukanov O S Amel'chugova N N Butorin O V Tret'iakova A V Vasiutin
author_sort	V V Tsukanov
title	Helicobacter pylori eradication: Current aspects
title_short	Helicobacter pylori eradication: Current aspects
title_full	Helicobacter pylori eradication: Current aspects
title_fullStr	Helicobacter pylori eradication: Current aspects
title_full_unstemmed	Helicobacter pylori eradication: Current aspects
title_sort	helicobacter pylori eradication: current aspects
publisher	"Consilium Medicum" Publishing house
series	Терапевтический архив
issn	0040-3660 2309-5342
publishDate	2013-02-01
description	The paper gives an update on the efficiency of Helicobacter pylori eradication. Triple therapy (a proton pump inhibitor + clarithromycin + amoxicillin) therapy is shown to hold top positions as first-line therapy for H. pylori eradication as before. The leading second-line therapy regimens are quadruple and 10-day triple schemes including levofloxacin. This point of view is supported by the Russian Gastroenterology Association. To reduce an increase in H. pylori resistance to clarithromycin, it is advisable to use Klacid (generic name: clarithromycin) in the eradication schemes.
topic	eradication helicobacter pylori helicobacter pylori
url	https://ter-arkhiv.ru/0040-3660/article/view/31227
work_keys_str_mv	AT vvtsukanov helicobacterpylorieradicationcurrentaspects AT osamelchugova helicobacterpylorieradicationcurrentaspects AT nnbutorin helicobacterpylorieradicationcurrentaspects AT ovtretiakova helicobacterpylorieradicationcurrentaspects AT avvasiutin helicobacterpylorieradicationcurrentaspects
_version_	1724672783972040704

Helicobacter pylori eradication: Current aspects

Similar Items